Survey and molecular genetics of SHV β-lactamases in Enterobacteriaceae in Switzerland: Two novel enzymes, SHV-11 and SHV-12

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 5, 1997, Pages 943-949

  Nüesch Inderbinen, Magdalena T ^a   Kayser, Fritz H ^a   Hächler, Herbert ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENETICS; ENTEROBACTERIACEAE; GENETIC EPIDEMIOLOGY; MOLECULAR GENETICS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SWITZERLAND;

EID: 0030935644     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.5.943     Document Type: Article

References (59)

1. Ambler, R. P., F. W. Coulson, J.-M. Frère, J.-M. Ghuysen, B. Joris, M. Forsman, R. C. Levesque, G. Tiraby, and S. G. Waley. 1991. A standard numbering scheme for the class A β-lactamases. Biochem. J. 276:269-270.
2. Anonymous. 1995. Problems in testing for β-lactamases still unsettled. ASM News 61:391-392.
3. Arakawa, Y., M. Otha, N. Kido, T. Komatsu, Y. Fujii, and N. Kato. 1986. Close evolutionary relationship between the chromosomally encoded β-lactamase gene of Klebsiella pneumoniae and the TEM β-lactamase gene mediated by R plasmids. FEBS Lett. 207:69-74.
4. Archambaud, M., G. Gerbaud, E. Labau, N. Marty, and P. Courvalin. 1991. Possible in-vivo transfer of beta-lactamase TEM-3 from Klebsiella pneumoniae to Salmonella kedougou. J. Antimicrob. Chemother. 27:427-436.
5. Barguellil, F., C. Burucoa, A. Amor, J. L. Fauchere, and C. Fendri. 1995. In vivo acquisition of extended-spectrum beta-lactamase in Salmonella enteritidis during antimicrobial therapy. Eur. J. Clin. Microbiol. Infect. Dis. 14:703-706.
6. Barthélémy, M., J. Peduzzi, and R. Labia. 1988. Complete amino acid sequence of p453-plasmid-mediated PIT-2 β-lacamase (SHV-1). Biochem. J. 251:73-79.
7. Bauernfeind, A., E. Rosenthal, E. Eberlein, M. Holley, and S. Schweighart. 1993. Spread of Klebsiella pneumoniae producing SHV-5 beta-lactamase among hospitalized patients. Infection 21:18-22.
8. Ben Hassen, A., M. Bejaoui, M. R. Lakhoua, and R. S. Ben. 1993. Epidemiological pattern of the resistance of 153 Salmonella strains (S. typhi excluded) isolated in a Tunisian pediatric unit from 1985 to 1990. Pathol. Biol. 41:706-712. (In French.)
9. Bouadallah, F., A. Benhassen, A. Gargouri, A. Boudabbous, and S. Benredjeb. 1996. Conjugative and non-conjugative plasmids in Salmonella serovar wien coding for broad-spectrum β-lactamase. Pathol. Biol. 44:701-704. (In French.)
10. Bradford, P. A., C. Urban, A. Jaiswal, N. Mariano, B. A. Rasmussen, S. J. Pojan, J. J. Rahal, and K. Bush. 1995. SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients. Antimicrob. Agents Chemother. 39:899-905.
11. Brosius, J., A. Ullrich, M. A. Raker, A. Gray, T. J. Dull, R. R. Gutell, and H. F. Noller. 1981. Construction and fine mapping of recombinant plasmids containing the rrnB ribosomal RNA operon of E. coli. Plasmid 6:112-118.
12. Bush, K. 1996. Is it important to identify extended-spectrum beta-lactamase-producing isolates? Eur. J. Clin. Microbiol. Infect. Dis. 15:361-364.
13. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
14. Cheng, Y., and M. Chen. 1994. Extended-spectrum beta-lactamases in clinical isolates of Enterobacter gergoviae and Escherichia coli in China. Antimicrob. Agents Chemother. 38:2838-2842.
15. De Champs, C., D. Sirot, C. Chanal, M. C. Poupart, M. P. Dumas, and J. Sirot. 1991. Concomitant dissemination of three extended-spectrum beta-lactamases among different Enterobacteriaceae isolated in a French hospital. J. Antimicrob. Chemother. 27:441-457.
16. French, G. L., K. P. Shannon, and N. Simmons. 1996. Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and beta-lactam-beta-lactamase inhibitor combinations by hyperproduction of SHV-5 beta-lactamase. J. Clin. Microbiol. 34:358-363.
17. Garbarg-Chenon, A., V. Godard, R. Labia, and J-C. Nicolas. 1990. Nucleotide sequence of SHV-2 β-lactamase gene. Antimicrob. Agents Chemother. 34:1444-1446.
18. Garbarg-Chenon, A., T. H. Vu, R. Labia, Y. H. Ben, V. Godard, P. Deny, F. Bricout, and J. C. Nicolas. 1989. Characterization of a plasmid coding for resistance to broad-spectrum cephalosporins in Salmonella typhimurium. Drugs Exp. Clin. Res. 15:145-150.
19. Gianneli, D., E. Tzelepi, L. S. Tzouvelekis, A. F. Mentis, and C. Nikolopoulou. 1994. Dissemination of cephalosporin-resistant Serratia marcescens strains producing a plasmidic SHV type beta-lactamase in Greek hospitals. Eur. J. Clin. Microbiol. Infect. Dis. 13:764-767.
20. Gutmann, L., B. Ferré, F. W. Goldstein, N. Rizk, E. Pinto-Schuster, J. F. Acar, and E. Collatz. 1989. SHV-5, a novel SHV-type β-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams. Antimicrob. Agents Chemother. 33:951-956.
21. Gutmann, L., M. D. Kitzis, D. Billot-Klein, F. Goldstein, G. Tran Van Nhieu, T. Lu, J. Carlet, E. Collatz, and R. Williamson. 1988. Plasmid-mediated beta-lactamase (TEM-7) involved in resistance to ceftazidime and aztreonam. Rev. Infect. Dis. 10:860-866.
22. Hammami, A., G. Arlet, S. Ben Redjeb, F. Grimont, A. Ben Hassen, A. Rekik, and A. Philippon. 1991. Nosocomial outbreak of acute gastroenteritis in a neonatal intensive care unit in Tunisia caused by multiply drug resistant Salmonella wien producing SHV-2. Eur. J. Clin. Microbiol. Infect. Dis. 10:641-646.
23. Issack, M. I., K. P. Shannon, S. A. Qureshi, and G. L. French. 1995. Extended-spectrum beta-lactamase in Salmonella spp. J. Hosp. Infect. 30:319-321. (Letter.)
24. Jacoby, G. A. 1994. Genetics of extended-spectrum beta-lactamases. Eur. J. Clin. Microbiol. Infect. Dis. 13:2-11.
25. Jacoby, G. A., and P. Han. 1996. Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J. Clin. Microbiol. 34:908-911.
26. Jacoby, G. A., and A. A. Medeiros. 1991. More extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 35:1697-1704.
27. Karas, J. A., D. G. Pillay, D. Muckart, and A. W. Sturm. 1996. Treatment failure due to extended spectrum beta-lactamase. J. Antimicrob. Chemother. 37:203-204.
28. Katsanis, G. P., J. Spargo, M. J. Ferraro, L. Sutton, and G. A. Jacoby. 1994. Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases. J. Clin. Microbiol. 32:691-696.
29. Kayser, F. H., G. Morenzoni, and F. Homberger. 1982. Activity of cefoperazone against ampicillin-resistant bacteria in agar and broth dilution tests. Antimicrob. Agents Chemother. 22:15-22.
30. Kliebe, C., B. Nies, J. F. Meyer, R. M. Tolxdorff-Neuzling, and B. Wiedemann. 1985. Evolution of plasmid-encoded resistance to broad-spectrum cephalosporins. Antimicrob. Agents Chemother. 28:302-307.
31. Lemozy, J., D. Sirot, C. Chanal, C. Huc, R. Labia, H. Dabernat, and J. Sirot. 1995. First characterization of inhibitor-resistant TEM (IRT) beta-lactamases in Klebsiella pneumoniae strains. Antimicrob. Agents Chemother. 39:2580-2582.
32. Livermore, D. M. 1995. β-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557-584.
33. Marchese, A., G. Arlet, G. C. Schito, P. H. Lagrange, and A. Philippon. 1996. Detection of SHV-5 extended-spectrum beta-laclamase in Klebsiella pneumoniae strains isolated in Italy. Eur. J. Clin. Microbiol. Infect. Dis. 15:245-248.
34. Martinez-Martinez, L., S. Hernandez-Alles, S. Alberti, J. M. Tomas, V. J. Benedi, and G. A. Jacoby. 1996. In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum cephalosporins. Antimicrob. Agents Chemother. 40:342-348.
35. Mercier, J., and R. C. Levesque. 1990. Cloning of SHV-2, OHIO-1, and OXA-6 β-lactamases and cloning and sequencing of SHV-1 β-lactamase. Antimicrob. Agents Chemother. 34:1577-1583.
36. Morosini, M. I., R. Canton, J. Martinez-Beltran, M. C. Negri, J. C. Perez-Diaz, F. Baquero, and J. Blazquez. 1995. New extended-spectrum TEM-type beta-lactamase from Salmonella enterica subsp. enterica isolated in a nosocomial outbreak. Antimicrob. Agents Chemother. 39:458-461.
37. Mulgrave, L., and P. V. Attwood. 1993. Characterization of an SHV-5 related extended broad-spectrum beta-lactamase in Enterobacteriaceae from Western Australia. Pathology 25:71-75.
38. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
39. National Committee for Clinical Laboratory Standards. 1993. Performance standards for antimicrobial disk susceptibility tests, 5th ed. Approved standard M2-A5. National Committee for Clinical Laboratory Standards. Villanova, Pa.
40. Nicolas, M.-H., V. Jarlier, N. Honore, A. Philippon, and S. T. Cole. 1989. Molecular characterization of the gene encoding SHV-3 β-lactamase responsible for transferable cefotaxime resistance in clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 33:2096-2100.
41. Nüesch-Inderbinen, M. T., H. Hächler, and F. H. Kayser. 1995. New system based on site-directed mutagenesis for highly accurate comparison of resistance levels conferred by SHV β-lactamases. Antimicrob. Agents Chemother. 39:1726-1730.
42. Nüesch-Inderbinen, M. T., H. Hächler, and F. H. Kayser. 1996. Detection of extended-spectrum SHV beta-lactamases in clinical isolates by a precise molecular genetic method and comparison with the E test. Eur. J. Clin. Microbiol. Infect. Dis. 15:398-402.
43. Philippon, A., G. Arlet, and P. H. Lagrange. 1994. Origin and impact of plasmid-mediated extended-spectrum beta-lactamases. Eur. J. Clin. Microbiol. Infect. Dis. 13:17-29.
44. Philippon, A., R. Labia, and G. A. Jacoby. 1989. Extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 33:1131-1136.
45. SHV) of Klebsiella pneumoniae. Nucleic Acids Res. 18:4916.
46. Podbielski, A., J. Schönling, B. Melzer, K. Warnatz, and H.-G. Leusch. 1991. Molecular characterization of a new plasmid-encoded SHV-type β-lactamase (SHV-2 variant) conferring high-level cefotaxime resistance upon Klebsiella pneumoniae. J. Gen. Microbiol. 137:569-578.
47. Prinarakis, E. E., E. Tzelepi, M. Gazouli, A. F. Mentis, and L. S. Tzouvelekis. 1996. Characterization of a novel SHV beta-lactamase variant that resembles the SHV-5 enzyme. FEMS Microbiol. Lett. 139:229-234.
48. Prodinger, W. M., M. Fille, A. Bauernfeind, I. Stemplinger, S. Amann, B. Pfausler, C. Lassflorl, and M. P. Dierich. 1996. Molecular epidemiology of Klebsiella pneumoniae producing SHV-5 beta-lactamase: parallel outbreaks due to multiple plasmid transfer. J. Clin. Microbiol. 34:564-568.
49. Rahal, K., and A. Reghal. 1994. A nosocomial epidemic of Salmonella mbandaka which produces various broad spectrum beta-lactamases: preliminary results. Med. Trop. 54:227-230. (In French.)
50. Raquet, X., M. Vanhove, J. Lamottebrasseur, S. Goussard, P. Courvalin, and J. M. Frere. 1995. Stability of TEM beta-lactamase mutants hydrolyzing third generation cephalosporins. Proteins Struct. Funct. Genet. 23:63-72.
51. Rice, L. B., L. L. Carias, R. A. Bonomo, and D. M. Shlaes. 1996. Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy. J. Infect. Dis. 173:151-158.
52. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
53. Sasaki, Y., N. Taketomo, and T. Sasaki. 1988. Factors affecting transfer frequency of pAMβ1 from Streptococcus faecalis to Lactobacillus plantarum. J. Bacteriol. 170:5939-5942.
54. Schultz, S. C., M. G. Dalbadie, J. J. Neitzel, and J. H. Richards. 1987. Stability of wild-type and mutant RTEM-1 beta-lactamases: effect of the disultide bond. Proteins 2:290-297.
55. Sirot, D. 1995. Extended-spectrum plasmid-mediated beta-lactamases. J. Antimicrob. Chemother. 36:19-34.
56. Southern, E. M. 1975. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:503-517.
57. Vahaboglu, H., L. Hall, L. Mulazimoglu, S. Dodanli, I. Yildirim, and D. M. Livermore. 1995. Resistance to extended-spectrum cephalosporins, caused by PER-1 beta-lactamase, in Salmonella typhimurium from Istanbul, Turkey. J. Med. Microbiol. 43:294-299.
58. Vatopoulos, A. C., A. Philippon, L. S. Tzouvelekis, Z. Komninou, and N. J. Legakis. 1990. Prevalence of a transferable SHV-5 type β-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece. J. Antimicrob. Chemother. 26:635-648.
59. Venezia, R. A., F. J. Scarano, K. E. Preston, L. M. Steele, T. P. Root, R. Limberger, W. Archinal, and M. A. Kacica. 1995. Molecular epidemiology of an SHV-5 extended-spectrum beta-lactamase in Enterobacteriaceae isolated from infants in a neonatal intensive care unit. Clin. Infect. Dis. 21:915-923.